Here are four things to note:
1. The app is part of the company’s trial for its Precision Spinal Cord System.
2. The trial is testing the Precision Plus and the Precision Spectra Spinal Cord Stimulator System. Both systems are wireless.
3. The app allows patients to record their pain levels and activities. The information will help physicians decide whether the SCS would be a helpful treatment for them.
4. The systems are placed under patients’ skin if they want to use them long-term. The information measured in the app proves invaluable, indicating whether the patient should move forward with the treatment before implanting the systems.
More articles on devices:
Zyga finishes $20M financing round: 5 key notes
Senate Finance Committee launches physician-owned distributorship hearings: 5 things to know
Orthofix shares falls 4.71% in the last week: 4 quick facts
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
